ENZON PHARMACEUTICALS, INC. Annual Income Tax Expense (Benefit) in USD from 2010 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Enzon Pharmaceuticals, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2010 to 2023.
  • Enzon Pharmaceuticals, Inc. Income Tax Expense (Benefit) for the quarter ending June 30, 2024 was $4K, a 92.3% decline year-over-year.
  • Enzon Pharmaceuticals, Inc. Income Tax Expense (Benefit) for the twelve months ending June 30, 2024 was -$168K, a 6.15% increase year-over-year.
  • Enzon Pharmaceuticals, Inc. annual Income Tax Expense (Benefit) for 2023 was -$156K, a 22% increase from 2022.
  • Enzon Pharmaceuticals, Inc. annual Income Tax Expense (Benefit) for 2022 was -$200K, a 2957% decline from 2021.
  • Enzon Pharmaceuticals, Inc. annual Income Tax Expense (Benefit) for 2021 was $7K, unchanged from 2020.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$156K +$44K +22% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-20
2022 -$200K -$207K -2957% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-20
2021 $7K $0 0% Jan 1, 2021 Dec 31, 2021 10-K 2023-02-16
2020 $7K +$1K +16.7% Jan 1, 2020 Dec 31, 2020 10-K 2022-02-25
2019 $6K $0 0% Jan 1, 2019 Dec 31, 2019 10-K 2021-02-23
2018 $6K -$1.56M -99.6% Jan 1, 2018 Dec 31, 2018 10-K 2020-02-19
2017 $1.56M -$6.21M -79.9% Jan 1, 2017 Dec 31, 2017 10-K 2019-02-21
2016 $7.77M +$18.6M Jan 1, 2016 Dec 31, 2016 10-K 2018-03-21
2015 -$10.8M -$10.9M -19452% Jan 1, 2015 Dec 31, 2015 10-K 2017-03-24
2014 $56K +$84K Jan 1, 2014 Dec 31, 2014 10-K 2016-03-21
2013 -$28K +$4.11M +99.3% Jan 1, 2013 Dec 31, 2013 10-K 2015-03-05
2012 -$4.14M -$4.34M -2117% Jan 1, 2012 Dec 31, 2012 10-K 2014-03-14
2011 $205K +$542K Jan 1, 2011 Dec 31, 2011 10-K 2014-03-14
2010 -$337K Jan 1, 2010 Dec 31, 2010 10-K 2013-03-18
* An asterisk sign (*) next to the value indicates that the value is likely invalid.